Paul La Rosée
12PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Dec 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.Philipp Ernst, Cera Lohse, Michael Lauseker
|Jan 18, 2024
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.Johanna Knauft, Thomas Schenk, Thomas Ernst
|Jul 28, 2023
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.J Hammersen, S Birndt, K Döhner
|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski
|Jun 11, 2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.F La Rosée, H C Bremer, I Gehrke
|Apr 18, 2019
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.Paul La Rosée, AnnaCarin Horne, Melissa Hines
Pageof 2
Frequent Collaborators
4 joint publications
Felicitas La Rosée
3 joint publications
Sebastian Birndt
3 joint publications
Andreas Hochhaus
2 joint publications
P Reuken
2 joint publications
Rafal Machowicz
2 joint publications
Thomas Ernst
1 joint publications
M M Rüthrich
1 joint publications
M Bauer
1 joint publications
A Stallmach
1 joint publications
G Illerhaus
